Medynmetis - Company finances
|
EUR
|
2024
From: 2024-04-23
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|
|
Financial data
|
||
| Sales revenue | 6,640 | 2,950 |
| Profit before tax | 3,508 | -12,387 |
| Net profit | 3,332 | -12,387 |
| Equity | 3,382 | -9,005 |
| Liabilities | 3,836 | 12,506 |
| Non-current assets | 5,810 | 18,093 |
| Current assets | 17,355 | 15 |
| Total assets | 23,165 | 18,108 |
|
Taxes paid
|
||
| STI taxes | - | 176 |
|
Financial indicators
|
||
| Revenue change y/y | - | -55.6% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 14.4% | -68.4% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 98.5% | - |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 50.2% | -419.9% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 52.8% | -419.9% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 1.1 | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Medynmetis - Social security debts
The amount of overdue SODRA debt for the company Medynmetis as of the last working day is: 73 €
| From | To | Debt, € |
|---|---|---|
| 2026-09-05 | 2026-09-16 | 73.44 |
| 2026-09-01 | 2026-09-02 | 73.44 |
| 2026-07-01 | 2026-07-31 | 81.93 |
| 2026-02-03 | 2026-02-28 | 0.07 |
| 2026-01-29 | 2026-01-31 | 66.61 |
| 2026-01-06 | 2026-01-28 | 232.72 |
| 2026-01-02 | 2026-01-05 | 108.90 |
| 2025-12-02 | 2026-01-01 | 196.42 |
| 2025-11-24 | 2025-12-01 | 72.60 |
| 2025-11-01 | 2025-11-23 | 160.12 |
| 2025-10-20 | 2025-10-31 | 36.30 |
| 2025-10-01 | 2025-10-19 | 123.82 |
| 2025-09-17 | 2025-09-30 | 87.52 |
| 2025-09-02 | 2025-09-16 | 413.92 |
| 2025-08-18 | 2025-09-01 | 253.95 |
| 2025-08-04 | 2025-08-17 | 341.47 |
| 2025-08-01 | 2025-08-03 | 130.13 |
| 2025-07-30 | 2025-07-31 | 57.68 |
| 2025-07-29 | 2025-07-29 | 145.20 |
| 2025-07-28 | 2025-07-28 | 57.68 |
| 2025-07-18 | 2025-07-27 | 145.20 |
| 2025-07-14 | 2025-07-17 | 108.90 |
| 2024-11-04 | 2024-12-31 | 129.00 |
| 2024-09-03 | 2024-11-03 | 64.50 |
| 2024-06-03 | 2024-06-30 | 64.50 |
Medynmetis - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Medynmetis, MB (company code 306730856) is a Lithuanian small partnership engaged in furniture manufacture. In the latest financial year, 2025, the company generated revenue of €3.0K, down 55.6% year on year from €6.6K in 2024. Profitability weakened sharply: net profit changed from a €3.3K gain in 2024 to a €12.4K loss in 2025, while the margin moved from a strong positive level to a deep loss as costs exceeded revenue by a wide margin. The balance sheet also deteriorated. Total assets decreased to €18.1K from €23.2K, equity turned negative at -€9.0K, and liabilities increased to €12.5K. Asset structure shifted significantly, with long-term assets at €18.1K and short-term assets only €15 at the end of 2025. The low revenue base and negative equity indicate a strained financial position, and the latest year shows materially weaker operating performance than 2024.